These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 2106763

  • 1. Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy.
    Sato M, Grasser W.
    J Bone Miner Res; 1990 Jan; 5(1):31-40. PubMed ID: 2106763
    [Abstract] [Full Text] [Related]

  • 2. Application of reflected light microscopy to identify and quantitate resorption by isolated osteoclasts.
    Walsh CA, Beresford JN, Birch MA, Boothroyd B, Gallagher JA.
    J Bone Miner Res; 1991 Jul; 6(7):661-71. PubMed ID: 1950671
    [Abstract] [Full Text] [Related]

  • 3. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro.
    Carano A, Teitelbaum SL, Konsek JD, Schlesinger PH, Blair HC.
    J Clin Invest; 1990 Feb; 85(2):456-61. PubMed ID: 2105340
    [Abstract] [Full Text] [Related]

  • 4. Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298.
    Coxon FP, Helfrich MH, Van't Hof R, Sebti S, Ralston SH, Hamilton A, Rogers MJ.
    J Bone Miner Res; 2000 Aug; 15(8):1467-76. PubMed ID: 10934645
    [Abstract] [Full Text] [Related]

  • 5. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo.
    Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman GD, Mundy GR, Boyce BF.
    J Bone Miner Res; 1995 Oct; 10(10):1478-87. PubMed ID: 8686503
    [Abstract] [Full Text] [Related]

  • 6. The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase.
    David P, Nguyen H, Barbier A, Baron R.
    J Bone Miner Res; 1996 Oct; 11(10):1498-507. PubMed ID: 8889850
    [Abstract] [Full Text] [Related]

  • 7. Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells.
    Coxon FP, Thompson K, Roelofs AJ, Ebetino FH, Rogers MJ.
    Bone; 2008 May; 42(5):848-60. PubMed ID: 18325866
    [Abstract] [Full Text] [Related]

  • 8. Effects of neridronic acid on osteoclasts derived by physiological dual-cell cultures.
    Nicolin V, Bareggi R, Baldini G, Bortul R, Martinelli B, Narducci P.
    Acta Histochem; 2007 May; 109(5):397-402. PubMed ID: 17574655
    [Abstract] [Full Text] [Related]

  • 9. Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.
    Sato M, Grasser W, Endo N, Akins R, Simmons H, Thompson DD, Golub E, Rodan GA.
    J Clin Invest; 1991 Dec; 88(6):2095-105. PubMed ID: 1661297
    [Abstract] [Full Text] [Related]

  • 10. The effect of dichloromethylene diphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing rat.
    Miller SC, Jee WS.
    Anat Rec; 1979 Mar; 193(3):439-62. PubMed ID: 154858
    [Abstract] [Full Text] [Related]

  • 11. Quantitative and reliable in vitro method combining scanning electron microscopy and image analysis for the screening of osteotropic modulators.
    Grimandi G, Soueidan A, Anjrini AA, Badran Z, Pilet P, Daculsi G, Faucheux C, Bouler JM, Guicheux J.
    Microsc Res Tech; 2006 Aug; 69(8):606-12. PubMed ID: 16718652
    [Abstract] [Full Text] [Related]

  • 12. Osteoclast activation: potent inhibition by the bisphosphonate alendronate through a nonresorptive mechanism.
    Owens JM, Fuller K, Chambers TJ.
    J Cell Physiol; 1997 Jul; 172(1):79-86. PubMed ID: 9207928
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of the inhibitory action of APD on the transformation of osteoclast precursors into resorbing cells after dimethylation of the amino group.
    Boonekamp PM, Löwik CW, van der Wee-Pals LJ, van Wijk-van Lennep ML, Bijvoet OL.
    Bone Miner; 1987 Feb; 2(1):29-42. PubMed ID: 3504722
    [Abstract] [Full Text] [Related]

  • 14. The effect of long-term low-dose diphosphonate treatment on rat bone.
    Evans RA, Howlett CR, Dunstan CR, Hills E.
    Clin Orthop Relat Res; 1982 May; (165):290-9. PubMed ID: 6210482
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow.
    Hughes DE, MacDonald BR, Russell RG, Gowen M.
    J Clin Invest; 1989 Jun; 83(6):1930-5. PubMed ID: 2524504
    [Abstract] [Full Text] [Related]

  • 16. Osteoblast proliferation and maturation by bisphosphonates.
    Im GI, Qureshi SA, Kenney J, Rubash HE, Shanbhag AS.
    Biomaterials; 2004 Aug; 25(18):4105-15. PubMed ID: 15046901
    [Abstract] [Full Text] [Related]

  • 17. In vitro comparison of clodronate, pamidronate and zoledronic acid effects on rat osteoclasts and human stem cell-derived osteoblasts.
    Kellinsalmi M, Mönkkönen H, Mönkkönen J, Leskelä HV, Parikka V, Hämäläinen M, Lehenkari P.
    Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):382-91. PubMed ID: 16364054
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of action of the bisphosphonates.
    Fleisch H.
    Medicina (B Aires); 1997 Dec; 57 Suppl 1():65-75. PubMed ID: 9567358
    [Abstract] [Full Text] [Related]

  • 19. Antitumor effects of bisphosphonates.
    Green JR.
    Cancer; 2003 Feb 01; 97(3 Suppl):840-7. PubMed ID: 12548584
    [Abstract] [Full Text] [Related]

  • 20. Reduction of instability-induced bone resorption using bisphosphonates: high doses are needed in rats.
    Astrand J, Aspenberg P.
    Acta Orthop Scand; 2002 Jan 01; 73(1):24-30. PubMed ID: 11928907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.